These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 29140108)
21. The role of cytokines in the establishment, persistence and eradication of the HIV reservoir. Vandergeeten C; Fromentin R; Chomont N Cytokine Growth Factor Rev; 2012; 23(4-5):143-9. PubMed ID: 22743037 [TBL] [Abstract][Full Text] [Related]
22. Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4. Garg A; Trout R; Spector SA Sci Rep; 2017 Mar; 7():44485. PubMed ID: 28338007 [TBL] [Abstract][Full Text] [Related]
23. The challenge of viral reservoirs in HIV-1 infection. Blankson JN; Persaud D; Siliciano RF Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490 [TBL] [Abstract][Full Text] [Related]
24. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Harari A; Rizzardi GP; Ellefsen K; Ciuffreda D; Champagne P; Bart PA; Kaufmann D; Telenti A; Sahli R; Tambussi G; Kaiser L; Lazzarin A; Perrin L; Pantaleo G Blood; 2002 Aug; 100(4):1381-7. PubMed ID: 12149221 [TBL] [Abstract][Full Text] [Related]
25. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. Abdel-Mohsen M; Wang C; Strain MC; Lada SM; Deng X; Cockerham LR; Pilcher CD; Hecht FM; Liegler T; Richman DD; Deeks SG; Pillai SK AIDS; 2015 Feb; 29(4):411-20. PubMed ID: 25602681 [TBL] [Abstract][Full Text] [Related]
26. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy. Sun H; Kim D; Li X; Kiselinova M; Ouyang Z; Vandekerckhove L; Shang H; Rosenberg ES; Yu XG; Lichterfeld M J Virol; 2015 Nov; 89(22):11284-93. PubMed ID: 26339043 [TBL] [Abstract][Full Text] [Related]
27. The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir. Veenhuis RT; Blankson JN Curr Top Microbiol Immunol; 2018; 417():43-67. PubMed ID: 29071476 [TBL] [Abstract][Full Text] [Related]
28. The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation. Brunt SJ; Lee S; D'Orsogna L; Bundell C; Burrows S; Price P Dis Markers; 2014; 2014():947432. PubMed ID: 25506120 [TBL] [Abstract][Full Text] [Related]
29. High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women. Giuliano M; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Ciccacci F; Amici R; Marazzi MC; Vella S; Palombi L; Mancinelli S J Clin Virol; 2017 Nov; 96():17-19. PubMed ID: 28918126 [TBL] [Abstract][Full Text] [Related]
30. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802 [TBL] [Abstract][Full Text] [Related]
31. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692 [TBL] [Abstract][Full Text] [Related]
32. Barriers to HIV Cure. Stein J; Storcksdieck Genannt Bonsmann M; Streeck H HLA; 2016 Oct; 88(4):155-63. PubMed ID: 27620852 [TBL] [Abstract][Full Text] [Related]
33. Human Cytomegalovirus Latency: Approaching the Gordian Knot. Goodrum F Annu Rev Virol; 2016 Sep; 3(1):333-357. PubMed ID: 27501258 [TBL] [Abstract][Full Text] [Related]
34. Aqueous humor immune factors and cytomegalovirus (CMV) levels in CMV retinitis through treatment - The CRIGSS study. Iyer JV; Agrawal R; Yeo TK; Gunasekeran DV; Balne PK; Lee B; Au VB; Connolly J; Teoh SC Cytokine; 2016 Aug; 84():56-62. PubMed ID: 27239802 [TBL] [Abstract][Full Text] [Related]
35. Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART. Karim B; Wijaya IP; Rahmaniyah R; Ariyanto I; Waters S; Estiasari R; Price P AIDS Res Ther; 2017 Aug; 14(1):52. PubMed ID: 28859681 [TBL] [Abstract][Full Text] [Related]
36. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Chomont N; El-Far M; Ancuta P; Trautmann L; Procopio FA; Yassine-Diab B; Boucher G; Boulassel MR; Ghattas G; Brenchley JM; Schacker TW; Hill BJ; Douek DC; Routy JP; Haddad EK; Sékaly RP Nat Med; 2009 Aug; 15(8):893-900. PubMed ID: 19543283 [TBL] [Abstract][Full Text] [Related]
37. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART. Sedaghat AR; Siliciano JD; Brennan TP; Wilke CO; Siliciano RF PLoS Pathog; 2007 Aug; 3(8):e122. PubMed ID: 17784786 [TBL] [Abstract][Full Text] [Related]
38. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. Harari A; Vallelian F; Meylan PR; Pantaleo G J Immunol; 2005 Jan; 174(2):1037-45. PubMed ID: 15634928 [TBL] [Abstract][Full Text] [Related]
39. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214 [TBL] [Abstract][Full Text] [Related]
40. A reservoir for HIV in patients on combination antiretroviral therapy. Siliciano RF Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]